" class="no-js "lang="en-US"> David Jenkins Discussing Antimicrobial Chemotherapy
Thursday, June 08, 2023

Breaking News

New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics Abivax Appoints Ida Hatoum as Chief People Officer Eureka Therapeutics Awarded $10.6 Million CIRM Grant to Support Clinical Trial of ARTEMIS® T-Cell Therapy in Pediatric Liver Cancer Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing FluoGuide Announces Positive Topline Results from Phase IIa Trial of FG001 in Lung Cancer

May 10 2023

David Jenkins, University Hospitals of Leicester, Discussing Antimicrobial Chemotherapy

In the video, David Jenkins, a consultant medical microbiologist from the University Hospitals of Leicester, discusses the issue of antibiotic resistance and the need for the development of new antibiotics. He also highlights the importance of organisations such as the British Society for Antimicrobial Chemotherapy (BSAC) in tackling this unmet need.

Jenkins also discusses how BSAC provides education to members through meetings and online webinars, as well as publishing leading journals.

Overall, Jenkins stresses the urgent need for action to address the growing problem of antibiotic resistance and calls for a collaborative effort between healthcare professionals, researchers, and policymakers to ensure the continued availability of effective antibiotics for the treatment of infectious diseases across not just the UK, but the world.

  1. New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes

    News

     Read more
  2. Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Clinical Trials

     Read more
  3. MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator

    News

     Read more
  4. XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer

    Appointments

     Read more
  5. Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics

    Gene Therapy

     Read more
More On